One of the causes of erectile dysfunction (ED) is the damaged penile cavernous smooth muscle cells (SMCs) and sinus endothelial cells (ECs). To investigate the feasibility of applying immortalized human mesenchymal stem cells (MSCs) to penile cavernous ECs or SMCs repair in the treatment of ED, the in vivo potential differentiation of the immortalized human MSCs toward penile cavernous endothelial or smooth muscle was investigated. One clone of immortalized human bone marrow mesenchymal stem cell line B10 cells via retroviral vector encoding v-myc were transplanted into the cavernosum of the Sprague-Dawley rats and harvested 2 weeks later. The expression of CD31, von Willebrand factor (vWF), smooth muscle cell actin (SMA), calponin and desmin was determined immunohistochemically in rat penile cavernosum. Multipotency of B10 to adipogenic, osteogenic or chondrogenic differentiation was found. Expression of EC specific markers (CD31 or vWF protein) and expression of SMC specific markers (calponin, SMA or desmin protein) were demonstrated in grafted B10 cells. When human MSCs were transplanted into the penile cavernosum, they have the potential to differentiate toward ECs or SMCs. Human MSCs may be a good candidate in the treatment of penile cavernosum injury.
Introduction
One of causes of erectile dysfunction (ED) is the damage in penile cavernous smooth muscle cells (SMCs) and sinus endothelial cells (ECs) by the various metabolic conditions or mechanical manipulations such as diabetes, hypertension, atherosclerosis or surgery, 1, 2 and accelerating repair of intact cavernous SMCs and sinus ECs repair can be a novel way in the treatment of ED.
Bone marrow contains two types of stem cells: hematopoietic stem cells and mesenchymal stem cells (MSCs). MSCs are a population of self-renewing stem cells with pluripotent capacity to differentiate into different cell types. 3 Previous studies have demonstrated in experimental animals that the MSCs transplanted into the brain, heart and other organs differentiate into cell types of host-grafted site. [3] [4] [5] [6] In a canine chronic ischemia model, MSCs differentiated into SMCs and ECs, resulting in increased vascularity and improved cardiac function. 5 Transplantation studies in mouse ischemia models also showed an engraftment at ischemic hind limb or myocardium lesions induced functional recovery. 7, 8 More recent studies in human patients have reported that the transplantation of autologous MSCs provided improvement in clinical outcome. 9, 10 Therefore, MSCs fulfill all criteria of true stem cells, that is, self-renewal, multilineage differentiation and in vivo reconstitution of tissue. 11 The major advantage of MSCs is the vast number of cells that can be harvested from one bone marrow aspirate. The relative ease of isolating MSCs from bone marrow and the great plasticity of the cells make them ideal tools for an autologous or allogeneic cell therapy.
Although previous studies have shown that MSCs transplantation can regenerate damaged vascular endothelium and myocardium, 12 it remains unknown whether MSCs can be used to repair penile cavernous smooth muscle and sinus endothelium. Because primary MSCs can be provided for only limited time before they undergo senescence, we have generated an immortalized human MSC cell line via retroviral vector encoding v-myc and utilized for the study to investigate if immortalized human MSCs could have the potential to differentiate toward ECs or SMCs.
Patients and methods
Primary cell culture Primary cultures of human bone marrow cells were obtained from fetal spinal vertebrae (14-18 weeks gestational age). The permission to use the fetal tissues was granted by the Clinical Screening Committee for Research involving human subjects of the University of British Columbia. Bone marrow cells were grown in modified Eagle medium -a (MEM-a) supplemented with 10% fetal bovine serum (FBS) and 25 mg/ml gentamicin. After the cultures reached confluency, the cells were lifted with phosphate-buffered saline (PBS) containing 0.1% trypsin and 1 mM ethylenediamine tetraacetic acid (EDTA) at 371C for 3 min and passaged into new dishes at 1:3 dilution.
Immortlized human MSC cell line
An amphotropic replication-incompetent retroviral vector encoding v-myc oncogene (transcribed from mouse leukemia virus LTR plus neomycin-resistant gene transcribed from a SV40 early promotor) was used to infect human fetal bone marrow MSCs inducing propagation of immortalized human bone marrow MSC cell lines (Figure 1a ). This amphotropic vector, LMmyc, was generated in our laboratory using the ecotropic retroviral vector encoding v-myc (ATCC, Manhasset, VA, USA) to infect PA317 amphotropic packaging cell line. MSCs were subjected to retrovirus-mediated transduction of v-myc Potential differentiation of human MSC in corpus cavernosum YS Song et al by LMmyc construct and subsequent cloning. Infection of human MSCs in 6-well plates was performed twice by the established procedures. Briefly, 2 ml of supernatant (4 Â 10 5 CFUs) from the packaging cell line and 8 mg/ml polybrene (Sigma, St Louis, MO, USA) were added to target cells in six-well plates and incubated for 4 h at 371C; the medium was then replaced with fresh growth medium; infection was repeated 24 h later. Seventy-two hours after the second infection, infected cells were selected with G418 (250 mg/ml; Sigma) for 7-14 days and large clusters of clonally derived cells were individually isolated and grown in six-well plates. Individual clones were generated by limited dilution and propagated further. At this phase of isolation, individual clones were designated as human MSC cell lines. One of these clones, B10 was subjected to further study. 
Differentiation culture conditions
Adipogenic differentiation of B10 cells was induced by growing the cells in a 6-well plate in Dulbecco's modified Eagle's medium (DMEM) containing 10% FBS, 5 mg/ml insulin, 1 mM dexamethasone, 100 nM indomethacin and 0.5 mM methylisobutylxanthine (Sigma) for 48 h, then cells were incubated in the same medium without dexamethasone. One week after the induction, cells were stained with oil-red. To induce osteogenic differentiation, B10 cells were cultured in DMEM containing 10 mM b-glycerophosphate, 0.2 mM ascorbate-2-phosphate and 10 nM dexamethasone. After 14 days, osteogenic differentiation was evaluated by alkaline phosphatase staining. For chondrogenic differentiation, pellets of B10 cell were cultured for 3 weeks in the presence of transforming growth factor-b1 (TGFb-1) in DM4 serum-free medium (DMEM containing 10 mg/ml human insulin, 10 mg/ml human transferrin, 3 nM sodium selenite, 5 nM hydrocortisone and 100 pM triiodothyronine). 13 This medium was replaced every 3-4 days for 21 days. Development of chondrogenic differentiation was determined by staining the pellet with Alcian blue.
Immunocytochemistry
Immunochemical determination of cell type-specific markers in B10 cells was performed as follows: B10 cells were grown on poly-D-lysine-coated Aclar plastic coverslips (9 mm in diameter) for 3-14 days, fixed in cold methanol for 10 min at À201C, air-dried and incubated with antibodies specific for each antigen marker. Cultures incubated with primary antibodies were followed by biotinylated secondary antibodies and avidin-biotin complex (ABC, Vector, Burlingame, CA, USA) and visualized with 3-amino-9-ethyl carbazole (Sigma) chromogen development. Cell type-specific markers used were CD31 and vWF for ECs, desmin, calponin and smooth muscle actin for SMCs. Cells were counterstained with 4 0 ,6-diamino-2-phenylindole (DAPI, Sigma) to identify cellular nuclei. Following immunostaining, cells were mounted on glass slides using gelvatol and viewed under an Olympus laser-scanning confocal microscope (Tokyo, Japan).
Transplantation of human MSCs into the rat penile cavernosum Ten week-old male Sprague-Dawley rats (300-320 g, n ¼ 20) were used in this study. Rats were anesthetized with 1% ketamine (30 mg/kg) and xylazine hydrochloride (4 mg/kg). The penile skin incision was made and the penile cavernosum was dissected and palpated. B10 human MSCs (1 Â 10 6 cells) were transplanted into the rat cavernosum using 500 ml syringe with 26G needle and the incised penile skin was sutured. To prevent rejection or infection, 10 mg/kg of intraperitoneal Cypol (cyclosporine; Chong Kun Dang, Seoul, Korea) with 10 mg/kg injection of Flomoxef (cephalosporin; Ildong, Seoul, Korea) was administered intraperitoneal daily. The penile cavernosum was harvested 2 weeks after the cell transplantation.
Immunofluorescence microscopy Each animal was anesthetized and perfused through the heart with 100 ml cold saline and 100 ml of 4% paraformaldehyde in PBS. After 24 h of fixation in 4% paraformaldehyde, the penis was cryoprotected with 30% sucrose for 24 h and cut into 30 mm sections in a cryostat (Leica CM 1900, Houston, TX, USA). Adjacent serial coronal sections were processed for human nuclear immunofluorescent staining with human antinuclear antibody (1:400, Chemicon & Abcam, Cambridge, MA, USA) to identify the human nuclear-positive, transplanted cells. Monoclonal antibodies specific for CD31 (1:200, R&D System, Mineapolis, MN, USA) and von Willebrand factor (1:100, R&D) were used for cell-type identification of ECs, whereas antibodies specific for smooth muscle a-actin (1:1000; Sigma), desmin (1:10 000, Chemicon, Temecula, CA, USA) and calponin (1:500; Sigma) for cell-type identification of SMCs. Penis sections were incubated in primary antibodies overnight at 41C as free-floating sections, and followed by Alexa Fluor 488-conju- 
Results

Phenotype of human MSCs
One of immortalized human mesenchymal stem cell lines, B10 were isolated. Phase contrast microscopy of primary human MSC culture and B10 human mesenchymal stem cell line showed spindle shape (Figure 1b) . Karyotype of B10 is 46, XX that is normal human karyotype (data not shown). B10 cells express cell type-specific markers for MSC markers CD29, CD44 and CD166 (Figure 1c ), but do not express cell type markers for hematopoietic stem cells CD24, CD34 or CD45 (data not shown).
Differentiation of human MSCs
After 7 days of culture in adipogenic culture medium, more than 80% of B10 MSCs differentiated into lipid-laden cells that stained with oil-red (Figure 2a) . Total cell numbers were counted by hematoxylin staining, and then the percentage of oil-red positive cells was calculated. After 14 days of culture in osteogenic medium, B10 MSCs differentiated into osteoblasts and this was confirmed by strong alkaline phosphatase staining (Figure 2c ). 14, 15 Differentiation of B10 MSCs into chondroblasts was determined by staining the cell pellets with Alcian blue, which positively identifies proteoglycan extracellular matrix, specific components of cartilage tissues ( Figure 2c ). As in primary human MSCs, B10 MSCs expressed markers of adipocytes, of osteoblasts and of chondrocytes following culture under the appropriate differentiation-inducing conditions. 6 
Properties of human MSCs
In B10 human MSCs, B10 cells expressing immunoreactivities against CD31 or vWF were not found indicating that the B10 cells do not differentiate into ECs (Figure 3) . In B10 human MSCs, B10 cells expressing immunoreactivities against desmin, calonin or smooth muscle actin protein were not found indicating that the B10 cells do not differentiate into SMCs (Figure 3 ).
Differentiation of human MSCs toward ECs
In penile sections transplanted earlier with B10 human MSCs, B10 cells expressing CD31 or vWF were found indicating that the B10 cells differentiated into ECs (Figure 4) . The merged cells expressing yellow fluorescence were CD31 þ or vWF þ cells that derived from B10 human MSCs (Figure 2 ). 
Differentiation of human MSCs toward SMCs
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Discussion
The integrity of cavernous ECs and SMCs is critical in maintaining and regulating erectile function. Accelerating intact ECs and SMCs repair is a key method for treating ED. Endothelial regeneration depends on the proliferation and migration of the adjacent uninjured ECs toward injury site and the recruitment of bone marrow-derived progenitor cells. [16] [17] [18] Several investigators have suggested that ex vivo expanded endothelial progenitor cells (EPCs) may contribute to re-endothelization after endothelial injury. 12, 19 However, one major criticism of studies describing plasticity of bone marrow cells is the heterogeneity of the cell population. EPCs show some phenotypic overlaps with hematopoietic cells and controversy still exists with respect to the identification and origin of EPCs. 20 MSCs are self-renewing and multipotential stem cells in the bone marrow. The human MSCs, with their attributes of (1) Potential differentiation of human MSC in corpus cavernosum YS Song et al ducible attributes from isolate to isolate, (5) reproducible characteristics in widely dispersed laboratories, (6) compatibility with tissue engineering principles and (7) potential to enhance repair in many vital tissues, may be the current preferred stem cell model for cellular therapeutic development. 21 One might expect allogenic MSCs would stimulate T-cell proliferation and that donor MSCs would be recognized by responder T cells and rejected by a recipient host. However, examination of the interaction of allogenic MSCs with cells of the immune system indicates little rejection by T cells. [22] [23] [24] Recent studies have shown that MSCs can acquire several features of mature ECs when cultured under optimal condition. 25 MSCs may therefore be an alternative source for EPCs. 26 Animal experiments have shown that MSCs can prevent deleterious remodeling and improve recovery after myocardial infarction. 21 Thus, it may be hypothesized that MSCs also contribute to replacement of SMCs after carvernous SMC loss.
Adult stem cells from bone marrow undergo milieu-dependent differentiation to express phenotypes that are similar to the cells in the local microenvironment. 27 Recent report suggested that cell fusion might explain some of the observed plasticity of adult stem cells. 28, 29 Our results support the possibility of the transplantability of MSCs and their potential utility in the treatment of ED. We examined the phenotype of human MSCs after in vivo transplantation to the penile cavernosum, and the grafted MSCs expressed EC antigens (CD31 and vWF) as well as SMC antigens (SMA, calponin or desmin) 30 after transplantation into the penile cavernosum. Therefore, these results show that MSCs have the milieu-dependent differentiation potential along endothelial and smooth muscle lineage when transplanted into the penile cavernosum.
Our study shows for the first time that human bone marrow-derived MSCs (CD29 þ CD44 þ CD166 þ ) are capable of differentiating into ECs and SMCs in vivo, which make them attractive candidates for cell therapy in patients suffering from ED. Although we found that the transplanted MSCs to penile cavernosum had the ability to differentiate The source of the cells that repair tissues after injury remains poorly defined and controversial. One possible source is stem cell-like progenitors that are endogenous to injured tissues. A second possible source is stem cells arising from the bone marrow that migrate to sites of tissue injury. One of the most interesting characteristics of MSCs is their ability to home to sites of tissue damage or inflammation. 31 The cells then either differentiate into the phenotypes of the damaged cells [32] [33] [34] or enhance repair by creating a microenvironment that promotes the local regeneration of cells endogenous to the tissue. 35, 36 It is not known if the in vivotransplanted MSCs act completely as a mature ECs or SMCs in the early phase following transplantation. However, it is possible that certain injuries on mature ECs or SMCs play the important role in the induction of MSC differentiation. 25 Our study has some limitations. First, at present, we do not know whether cellular therapy may help or hurt penile erectile function. Therefore, our results should be confirmed in immunocompromised animals, since human stem cells are not compatible in nonimmunocompromised animals. Second, the broad differentiation potential of bone marrow-derived stem cells to liver cells, cardiomyocytes and neuron, have been suggested. However, cell fusion may contribute to the development or maintenance of these key cell types. 37 In addition, Y-chromosome-positive cells with apparent neuronal or cardiomyocyte function of female bone marrow transplant recipients have been noted in the brains and hearts, respectively. 38, 39 Although these observations have been interpreted as evidence of differentiation of the incoming donor cells and subsequent population of host organs, these may be explained as the result of spontaneous fusion of host and donor cells. [40] [41] [42] Therefore, it is difficult to prove the differentiation.
Conclusions
When human MSCs were transplanted into adult rat penile cavernosum, they differentiated toward ECs or SMCs. Thus, human MSCs should serve as a good candidate in the treatment of ED. With the further elucidation of the mechanisms for differentiation of MSCs, human MSCs transplantation might become a new potent strategy for the management of ED.
